Search - tctmd.com

Displaying 41 - 60 of 98

Sort: Relevancy | Date

Regenerative Medicine Applied to Machine Perfusion

Presentation THT 2023

Regenerative Medicine Applied to Machine Perfusion

Presenter: NULL

March 21, 2023

Bleeding as Mortality Surrogate Questioned for Antithrombotic Trials

News Daily News

Bleeding as Mortality Surrogate Questioned for Antithrombotic Trials

March 16, 2023

The Biggest News of 2022: TCTMD’s Top 10

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

December 30, 2022

Vitamin D Doesn’t Reduce Statin-Associated Muscle Symptoms VITAL

News Daily News

Vitamin D Doesn’t Reduce Statin-Associated Muscle Symptoms: VITAL

Michael O'Riordan

November 25, 2022

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

November 18, 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

November 09, 2022

From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF

News Daily News

From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF

October 27, 2022

Anatomic Features Key for Selecting Patients Best Suited to PFO Closure

News Daily News

Anatomic Features Key for Selecting Patients Best Suited to PFO Closure

Yael L. Maxwell

October 14, 2022

COVID-19: TCTMD’s Dispatch for September 26

News Daily News

COVID-19: TCTMD’s Dispatch for September 26

September 26, 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

Infertility in Women Linked to Subsequent Risk of HFpEF

News Daily News

Infertility in Women Linked to Subsequent Risk of HFpEF

April 19, 2022

Best Exercise for Heart Health? Some Hints of Intensity’s Role

News Daily News

Best Exercise for Heart Health? Some Hints of Intensity’s Role

Michael O'Riordan

December 02, 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

November 15, 2021

Leading with Evidence: Latest Data on Renal Denervation

Presentation TCT 2021

Leading with Evidence: Latest Data on Renal Denervation

Presenter: NULL

November 06, 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

November 05, 2021

Latest Evidence in the SPYRAL-HTN Clinical Program

Presentation TCT 2021

Latest Evidence in the SPYRAL-HTN Clinical Program

Presenter: NULL

November 05, 2021

Scanning Laser Angioscopy: A New High-Resolution Multimodal Platform for Intravascular Diagnosis and Therapy

Presentation TCT 2021

Scanning Laser Angioscopy: A New High-Resolution Multimodal Platform for Intravascular Diagnosis and Therapy

Presenter: NULL

November 05, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

October 11, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.